KOSDAQFood & Beverage260970

S&D

₩61,200▲ 0.99%2026-10-02 close

Market Cap

₩177.6B

Turnover

₩500M

Volume

8,494 shares

Shares out.

2.9M

PER

6.4×

PBR

1.7×

EPS

₩8,380

Dividend Yield

3.31%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩1,790 per share · Prices as of the 2026-10-02 close

Report overview

Buldak Tailwind Meets Customer Concentration Risk

S&D is a food ingredient maker whose growth has centered on supplying Buldak Bokkeummyeon sauce materials to Samyang Foods, combining capacity-driven earnings improvement with structural customer-concentration risk.

1
2025 revenue reached KRW 150.9bn and operating profit KRW 23.0bn, up 30.0% and 14.4% year-on-year, respectively.
2
Quarterly revenue set consecutive highs of KRW 45.5bn (1Q26) and KRW 49.9bn (2Q26).
3
Roughly 80% or more of revenue comes from Buldak Bokkeummyeon sauce materials supplied to Samyang Foods, resulting in very high customer concentration.
4
Samyang's acquisition of sauce maker GNF has raised concerns about potential supply-chain insourcing.
5
Completion of a second plant in the second half of 2025 expanded capacity, with the effect now feeding into 2026 results.

Business structure

Founded in 1998, S&D is a food ingredient specialist that listed on KONEX in 2016 and moved to KOSDAQ in 2021. Its business is built around two pillars: general functional food materials such as grill concentrates, cheese powders, and spicy-taste base powders, and natural-material health functional food ingredients.

The bulk of revenue comes from sauce materials for Samyang Foods' Buldak Bokkeummyeon noodles, including chicken-flavor powder and grill chicken concentrate, with Samyang alone reportedly accounting for roughly 80% or more of total revenue.

Beyond Samyang, the company serves about 160 customers including CJ CheilJedang, Nongshim, and Pulmuone. Production is based in the Osong Life Science Complex in North Chungcheong Province, where a dedicated health functional food plant was completed in 2022.

The company holds patents related to chicken-flavor manufacturing processes, giving its formulation know-how a degree of competitive protection.

More recently, it has been exploring its own branded consumer products such as powdered seasonings and ready meals, moving beyond a pure B2B ingredient-supply model to reduce customer dependence.

Earnings trend

Quarterly revenue · Operating profit

₩38.1B₩6B25Q2₩39B₩6.1B25Q3₩38.1B₩5.5B25Q4₩45.5B₩8.1B26Q1₩49.9B₩8.3B26Q2

RevenueOperating profit

Annual revenue · Operating profit

₩73.3B₩10.9B2022₩88.3B₩12.9B2023₩116.1B₩20.1B2024₩150.9B₩23B2025

RevenueOperating profit

Quarterly results · Last 5 quarters
Quarter	Revenue	Operating profit	Op. margin
2025Q2	₩38.1B	₩6B	15.7%
2025Q3	₩39B	₩6.1B	15.6%
2025Q4	₩38.1B	₩5.5B	14.5%
2026Q1	₩45.5B	₩8.1B	17.9%
2026Q2	₩49.9B	₩8.3B	16.6%

Annual results
Year	Revenue	Operating profit	Net income (parent)	Op. margin	ROE	Debt-to-equity
2022	₩73.3B	₩10.9B	₩9.8B	14.9%	12.6%	19.5%
2023	₩88.3B	₩12.9B	₩11.9B	14.6%	13.4%	19.7%
2024	₩116.1B	₩20.1B	₩17B	17.3%	25.0%	36.7%
2025	₩150.9B	₩23B	₩20.6B	15.2%	23.9%	26.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23

Earnings analysis

Consolidated 2025 revenue rose 30.0% year-on-year to KRW 150.9bn, operating profit grew 14.4% to KRW 23.0bn, and net profit attributable to owners increased 21.0% to KRW 20.6bn.

The operating margin eased slightly from 17.3% in 2024 to 15.2% in 2025, a partial reversal of the improving trend seen from 14.9% (2022) to 14.6% (2023) to 17.3% (2024), likely reflecting cost pressure.

On a quarterly basis, revenue rose gently from KRW 38.1bn with KRW 6.0bn operating profit in 2Q25 to KRW 39.0bn and KRW 6.1bn in 3Q25, while 4Q25 revenue held at KRW 38.1bn with operating profit softening to KRW 5.5bn even as net profit rose to KRW 6.4bn, suggesting a one-off non-operating item may have contributed.

Momentum accelerated into 2026, with 1Q26 revenue jumping to KRW 45.5bn and operating profit to KRW 8.1bn (17.9% margin), followed by a fresh quarterly record of KRW 49.9bn in revenue and KRW 8.3bn in operating profit (16.6% margin) in 2Q26.

Combined net profit attributable to owners over the most recent four quarters (3Q25-2Q26) reached KRW 24.2bn, already exceeding full-year 2025 net profit of KRW 20.6bn. Operating cash flow expanded steadily from KRW 8.3bn in 2022 to KRW 22.8bn in 2025, indicating improving cash conversion of earnings.

The debt ratio, which climbed to 36.7% in 2024 amid capacity investment, eased back to 26.3% in 2025, pointing to a stabilizing balance sheet following the capex cycle.

Industry analysis

South Korea's instant noodle exports are on a structural growth path driven by the global K-food boom. In the first half of 2026, Korean ramyeon exports reached USD 935.39 million, up 28% year-on-year and a record for a half-year period.

Samyang Foods leads this growth, accounting for more than 60% of total ramyeon exports, with Buldak Bokkeummyeon surpassing cumulative sales of 10 billion units as of late May 2026.

Samyang has diversified its export base from a China/Asia-centric mix toward the Americas and Europe, with Buldak's US Walmart penetration exceeding 90% and Costco over 50%.

By contrast, rivals Nongshim and Ottogi derive more than 90% of sales domestically and have grown exports more slowly; in 1Q26, Samyang's operating margin of 24.8% far outpaced Nongshim's 7.2% and Ottogi's 6.2%.

S&D's performance is directly tied to Samyang's overseas growth, as expanding exports translate into higher ingredient orders.

However, since Samyang Roundsquare, Samyang's holding company, acquired sauce maker GNF in July 2025, the market has held divided views on whether this signals supply-chain insourcing risk or coexistence alongside S&D's supply position.

Samyang's capacity expansion is expected to continue, with the Miryang No.2 plant's output fully reflected in 2026 results and a China plant with annual capacity of 1.13 billion units slated to start operations from 2027.

Outlook

The company completed a KRW 16bn plant-expansion investment announced in December 2024 by June 2025, and finished a second plant in the second half of 2025 to expand capacity. Consecutive quarterly revenue and operating profit records in 1Q26 and 2Q26 suggest this capacity effect is now flowing through to results.

Consensus estimates for customer Samyang Foods' 2026 revenue stand at KRW 2.989 trillion and operating profit at KRW 708.2bn, up 27.7% and 41.7% respectively from a year earlier — an upward revision that could positively correlate with S&D's future order volumes.

Samyang plans to start a China plant with annual capacity of 1.13 billion units from 2027, which could further expand S&D's volume base over the medium term.

Separately, the company is reportedly exploring its own branded finished products such as powdered seasoning and HMR meals to diversify its revenue base, though specific launch timing or sales targets have not been officially confirmed.

How Samyang's sourcing strategy evolves following the GNF acquisition, and how the stabilization of GNF's production lines affects S&D's future order allocation, remain variables that require ongoing monitoring.

Valuation

PER

6.4×

PBR

1.7×

ROE

28.7%

EPS

₩8,380

BPS

₩32,500

Dividend per share

₩1,790

One brokerage report noted that in its early listing period, S&D at times traded at a lower net-profit multiple than the average of peer food ingredient companies (Eugene Investment & Securities, December 2023).

Since then, as earnings improved steadily each year, the market's valuation assessment has evolved alongside it. The five-year average price-to-book ratio has been compiled at around 1.7 times, and the current book-value multiple sits within that historical band.

Dividends have been paid annually, but the payout ratio itself remains on the low side, leaving room for discussion on whether shareholder returns could expand in line with earnings growth.

How the market values the stock going forward may depend on the durability of the Samyang relationship, the persistence of the capacity-expansion effect, and the progress of the company's own-brand business.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23

Bull factors

Direct Beneficiary of Structural K-Ramyeon Export Growth

Korean ramyeon exports rose 28% year-on-year in the first half of 2026, a record half-year figure, and consensus estimates for export leader Samyang Foods have been revised sharply higher over the past year.

Because S&D's ingredient sales are directly tied to Samyang's overseas volumes, expanding exports have translated into rising order volumes. Consecutive quarterly revenue records in 1Q26 and 2Q26 demonstrate that this linkage is materializing in practice.

Capacity-Expansion Effect Now Flowing Into Results

Capacity expanded after a KRW 16bn plant-expansion decision from December 2024 was completed in June 2025, followed by the second plant's completion in the second half of 2025. The rise in operating margin to 17.9% in 1Q26 can be interpreted as reflecting fixed-cost dilution from higher utilization.

With the major capex cycle largely behind it, the company is positioned for a phase of steadier operating cash flow expansion.

Entry Barrier from Proprietary Patents and Know-How

S&D holds patents related to chicken-flavor manufacturing methods, positioning it as a materials developer with formulation know-how rather than a mere commodity supplier. This technical barrier makes it harder for customers to easily substitute sourcing.

The company's recent exploration of its own branded consumer products can be seen as an attempt to extend this technical capability into finished goods.

Bear factors

Bargaining-Power Risk From Samyang Concentration

With roughly 80% or more of revenue concentrated in a single customer, Samyang Foods, changes in the customer's sourcing strategy carry outsized impact on results.

After Samyang's holding company acquired sauce maker GNF in 2025, the market raised concerns about potential supply-chain insourcing and a resulting erosion of S&D's pricing power.

The company itself stated it had not been informed in advance, leaving information asymmetry regarding the customer's strategic shifts as a lingering risk factor.

Cycle Risk From Reliance on a Single Buldak Brand

S&D's growth is largely dependent on the global success of a single brand, Buldak Bokkeummyeon. If the spicy-food trend cools or regulatory or health concerns emerge in particular markets, a slowdown in Samyang's sales could directly translate into reduced orders for S&D.

This is cited as a structural vulnerability given the absence of a clearly established alternative revenue source.

Uncertain Durability of Margin Improvement

The operating margin fell from 17.3% in 2024 to 15.2% in 2025 before recovering to 17.9% in 1Q26, showing considerable quarter-to-quarter volatility. This suggests sensitivity to variables such as utilization rates, raw material costs, and product mix.

As seen in 4Q25, when net profit rose even as operating profit declined, one-off items cannot be ruled out, making it difficult to read the margin trend in a straightforward manner.

Risk factors

Customer Concentration Risk

With most revenue dependent on a single customer, Samyang Foods, any change in that company's procurement policy or negotiating strategy could directly hit S&D's results. The possibility of supply-chain insourcing following the GNF acquisition has not been fully resolved. Revenue diversification is underway but its contribution appears still limited.

FX and Tariff Risk

Since most of customer Samyang's revenue comes from exports, changes in tariff policy in major markets such as the United States, or a stronger won, could affect end-price competitiveness and volumes. This structure means such factors could indirectly affect S&D's ingredient order volumes as well.

Facility and Environmental Regulation Risk

Given the nature of food-ingredient manufacturing, the company faces ongoing investment burdens related to wastewater treatment and air-emission facilities. As production capacity expands, related facility investment and regulatory compliance costs could rise, potentially weighing on margins in the near term.

What to watch next

Mid-November 2026
Filing of the 3Q26 quarterly report — a key point to check whether the capacity-expansion effect persists and how the operating margin trends.
4Q 2026 through early 2027
Progress on Samyang's China plant preparations — updates on the plant slated to start in 2027 could affect S&D's medium-term order base.
Ongoing monitoring
Disclosures or news on the stabilization of Samyang's GNF production lines and its sauce-sourcing strategy — the impact on S&D's order allocation warrants continuous monitoring.
Early 2027
Announcement of full-year 2026 results and dividends — a point to check margins and the shareholder-return policy in the first year fully reflecting the capacity expansion.

Overall view

S&D is a food ingredient company whose revenue and profit have grown structurally on the back of Samyang Foods' global Buldak Bokkeummyeon success. 2025 revenue rose 30.0% year-on-year to KRW 150.9bn, and consecutive quarterly records in revenue and operating profit through 1Q26 and 2Q26 mark a phase in which the effect of the second plant completed in the second half of 2025 is now flowing into results.

Even so, dependence on a single customer, Samyang, for roughly 80% or more of revenue remains a structural feature, and market interpretations have diverged over the potential for supply-chain insourcing following the 2025 acquisition of sauce maker GNF by Samyang's holding company.

The operating margin eased slightly in 2025 after peaking in 2024 before rising again in 2026, showing quarter-to-quarter volatility that makes a linear read on margins difficult.

Dividends have been paid annually, but the payout ratio remains on the low side, leaving room for discussion on future shareholder-return expansion. Overall, the stock represents a case where direct exposure to K-ramyeon export growth coexists with the structural risk of customer concentration.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 18 more articles and sources

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.